Comparison of neointimal formation in polymer-free Paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials)

American Journal of Cardiology

Volumn 94, Issue 2, 2004, Pages 199-201

  Kałuza, Grzegorz L ^a   Gershlick, Anthony H ^b   Park, Seung Jung ^b   De Scheerder, Ivan ^b   Chevalier, Bernard ^b   Camenzind, Edoardo ^b   Goy, Jean Jacques ^b   Missault, Luc ^b   Reifart, Nicolaus ^b   Vrints, Christiaan ^b   Urban, Philip ^b   Shim, Won Heum ^b   Ho, David Sai Wah ^b   Fearnot, Neal E ^b   Voorhees III, William D ^b   Raizner, Albert E ^b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; POLYMER; STAINLESS STEEL;

ANGIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTERY OCCLUSION; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ELUTING STENT; DRUG MEGADOSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURFACE PROPERTY;

ANGIOGENESIS INHIBITORS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERPLASIA; PACLITAXEL; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; STAINLESS STEEL; STENTS; TUNICA INTIMA;

EID: 3142528472     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.03.063     Document Type: Article

References (15)

1. Rankin J.M., Spinelli J.J., Carere R.G., Ricci D.R., Penn I.M., Hilton J.D., Henderson M.A., Hayden R.I., Buller C.E. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med. 341:1999;1957-1965
2. Baim D.S., Cutlip D.E., Midei M., Linnemeier T.J., Schreiber T., Cox D., Kereiakes D., Popma J.J., Robertson L., Prince R., et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 87:2001;157-162
3. Baim D.S., Cutlip D.E., O'Shaughnessy C.D., Hermiller J.B., Kereiakes D.J., Giambartolomei A., Katz S., Lansky A.J., Fitzpatrick M., Popma J.J., et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 87:2001;152-156
4. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 349:2003;1315-1323
5. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 350:2004;221-231
6. Park S.J., Shim W.H., Ho D.S., Raizner A.E., Park S.W., Hong M.K., Lee C.W., Choi D., Jang Y., Lam R., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 348:2003;1537-1545
7. Gershlick A., De Scheerder I., Chevalier B., Stephens-Lloyd A., Camenzind E., Vrints C., Reifart N., Missault L., Goy J.J., Brinker J.A., et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent. The European Evaluation of Paclitaxel Eluting Stent (ELUTES) trial. Circulation. 109:2004;487-493
8. Sabate M., Costa M.A., Kozuma K., Kay I.P., van der Wiel C.J., Verin V., Wijns W., Serruys P.W. Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy. Dose Finding Study Group. J Am Coll Cardiol. 36:2000;1536-1541
9. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 108:2003;788-794
10. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Angiographic patterns of in-stent restenosis classification and implications for long-term outcome. Circulation. 100:1999;1872-1878
11. Lansky A.J., Dangas G., Mehran R., Desai K.J., Mintz G.S., Wu H., Fahy M., Stone G.W., Waksman R., Leon M.B. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol. 39:2002;274-280
12. Lemos P.A., Saia F., Ligthart J.M., Arampatzis C.A., Sianos G., Tanabe K., Hoye A., Degertekin M., Daemen J., McFadden E., et al. Coronary restenosis after sirolimus-eluting stent implantation morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 108:2003;257-260
13. Kobayashi Y., De Gregorio J., Kobayashi N., Akiyama T., Reimers B., Finci L., Di Mario C., Colombo A. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 34:1999;651-659
14. Garasic J.M., Edelman E.R., Squire J.C., Seifert P., Williams M.S., Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 101:2000;812-818
15. Hwang C.W., Wu D., Edelman E.R. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 104:2001;600-605